title: The DNA replication checkpoint response stabilizes stalled replication forks.
abstract: In response to DNA damage and blocks to replication, eukaryotes activate the checkpoint pathways that prevent genomic instability and cancer by coordinating cell cycle progression with DNA repair. In budding yeast, the checkpoint response requires the Mec1-dependent activation of the Rad53 protein kinase. Active Rad53 slows DNA synthesis when DNA is damaged and prevents firing of late origins of replication. Further, rad53 mutants are unable to recover from a replication block. Mec1 and Rad53 also modulate the phosphorylation state of different DNA replication and repair enzymes. Little is known of the mechanisms by which checkpoint pathways interact with the replication apparatus when DNA is damaged or replication blocked. We used the two-dimensional gel technique to examine replication intermediates in response to hydroxyurea-induced replication blocks. Here we show that hydroxyurea-treated rad53 mutants accumulate unusual DNA structures at replication forks. The persistence of these abnormal molecules during recovery from the hydroxyurea block correlates with the inability to dephosphorylate Rad53. Further, Rad53 is required to properly maintain stable replication forks during the block. We propose that Rad53 prevents collapse of the fork when replication pauses.
authors.affiliation: Istituto F.I.R.C. di Oncologia Molecolare, Via Serio 21, 20141, Milano, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Lopes
authors.forename: C
authors.initials: C
authors.lastname: Cotta-Ramusino
authors.forename: A
authors.initials: A
authors.lastname: Pellicioli
authors.forename: G
authors.initials: G
authors.lastname: Liberi
authors.forename: P
authors.initials: P
authors.lastname: Plevani
authors.forename: M
authors.initials: M
authors.lastname: Muzi-Falconi
authors.forename: C S
authors.initials: CS
authors.lastname: Newlon
authors.forename: M
authors.initials: M
authors.lastname: Foiani
mesh_terms: D002453:Cell Cycle / Q000235:genetics / Q000502:physiology; D018797:Cell Cycle Proteins; D064447:Checkpoint Kinase 2; D004261:DNA Replication; D004271:DNA, Fungal / Q000096:biosynthesis* / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006918:Hydroxyurea / Q000494:pharmacology; D009154:Mutation; D009690:Nucleic Acid Conformation; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D018741:Replication Origin; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D029701:Saccharomyces cerevisiae Proteins; D004718:Saccharomycetales
chemical_list: D018797:Cell Cycle Proteins; D004271:DNA, Fungal; D004791:Enzyme Inhibitors; D019384:Nucleic Acid Synthesis Inhibitors; D029701:Saccharomyces cerevisiae Proteins; D012264:Ribonucleotide Reductases; D064447:Checkpoint Kinase 2; D017346:Protein Serine-Threonine Kinases; C067022:RAD53 protein, S cerevisiae; D006918:Hydroxyurea